News

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...
The U.S. Food and Drug Administration has approved Yeztugo (lenacapavir), an injectable HIV-1 capsid inhibitor, as ...
The Food and Drug Administration has approved a new, first-of-its-kind semiannual HIV prevention medication, Gilead Sciences ...
The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...
The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.
FDA Approves Yeztugo as First Twice-Yearly Injectable HIV Prevention Option in the U.S. Clinical Trials Show Near-Perfect ...
According to its creator, Gilead Sciences, lenacapavir will be marketed under the trade name Yeztugo. The company has committed to manufacturing 10 million doses by 2026. “This is a historic day in ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
On Wednesday, the Food and Drug Administration approved a highly effective, injectable drug to help prevent the transmission ...
The U.S. Food and Drug Administration approved an HIV prevention medication that has been proven highly effective in clinical ...
The FDA has approved a new, twice-yearly PrEP injection from pharmaceutical giant Gilead. The drug is lenacapavir. The ...